Clinical Trial

Oat and Cholesterol

Study Description

Oat and Cholesterol

The primary objective is to assess the effect of an oat ingredient provided over 4 weeks on serum LDL cholesterol in men and women with elevated LDL-cholesterol compared to a placebo. Secondary endpoints are fasting serum total- and HDL-cholesterol, non-HDL-cholesterol, triglycerides, glucose, insulin, glycated albumin, HOMA-IR and Framingham risk score

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Active oat beverage

Powder packaged in sachets, mixed with water and consumed 3 times per day for 1 month

Control rice beverage

Powder packaged in sachets, mixed with water and consumed 3 times per day for 1 month

Additional Information

Official Study Title

Impact of Oat Product on LDL Cholesterol in Healthy Men and Women With Elevated LDL-cholesterol

Clinical Trial ID

NCT03911427

ParticipAid ID

aKr28e